Skip to main content
Premium Trial:

Request an Annual Quote

Codex DNA SARS-CoV-2 Synthetic Genomes for UK and South Africa Variants

Codex DNA has released full-length synthetic genomes for the emerging SARS-CoV-2 variants B.1.1.7 and B.1.351, identified in the UK and South Africa, respectively.

The genomes are synthesized de novo on Codex DNA's BioXp 3250 system and can be used in developing vaccines, therapeutics, and diagnostics for COVID-19 research. They can be activated for use in monoclonal antibody therapy or vaccine development or serve as diagnostic controls.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.